CVM
Price
$2.10
Change
-$0.26 (-11.02%)
Updated
May 30 closing price
Capitalization
6.58M
CYTK
Price
$31.02
Change
-$0.30 (-0.96%)
Updated
May 30 closing price
Capitalization
3.7B
60 days until earnings call
Interact to see
Advertisement

CVM vs CYTK

Header iconCVM vs CYTK Comparison
Open Charts CVM vs CYTKBanner chart's image
Cel-Sci
Price$2.10
Change-$0.26 (-11.02%)
Volume$430.78K
Capitalization6.58M
Cytokinetics
Price$31.02
Change-$0.30 (-0.96%)
Volume$1.25M
Capitalization3.7B
CVM vs CYTK Comparison Chart
Loading...
CVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CVM vs. CYTK commentary
Jun 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVM is a Buy and CYTK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 01, 2025
Stock price -- (CVM: $2.10 vs. CYTK: $31.02)
Brand notoriety: CVM: Notable vs. CYTK: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVM: 295% vs. CYTK: 54%
Market capitalization -- CVM: $6.58M vs. CYTK: $3.7B
CVM [@Biotechnology] is valued at $6.58M. CYTK’s [@Biotechnology] market capitalization is $3.7B. The market cap for tickers in the [@Biotechnology] industry ranges from $303.58B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVM’s FA Score shows that 0 FA rating(s) are green whileCYTK’s FA Score has 1 green FA rating(s).

  • CVM’s FA Score: 0 green, 5 red.
  • CYTK’s FA Score: 1 green, 4 red.
According to our system of comparison, CYTK is a better buy in the long-term than CVM.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVM’s TA Score shows that 4 TA indicator(s) are bullish while CYTK’s TA Score has 5 bullish TA indicator(s).

  • CVM’s TA Score: 4 bullish, 6 bearish.
  • CYTK’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, CYTK is a better buy in the short-term than CVM.

Price Growth

CVM (@Biotechnology) experienced а -16.33% price change this week, while CYTK (@Biotechnology) price change was +1.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.39%. For the same industry, the average monthly price growth was +0.48%, and the average quarterly price growth was -5.03%.

Reported Earning Dates

CVM is expected to report earnings on May 15, 2025.

CYTK is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+1.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYTK($3.71B) has a higher market cap than CVM($6.58M). CYTK YTD gains are higher at: -34.056 vs. CVM (-82.496). CVM has higher annual earnings (EBITDA): -21.96M vs. CYTK (-513.62M). CVM has less debt than CYTK: CVM (11.1M) vs CYTK (791M). CYTK has higher revenues than CVM: CYTK (19.2M) vs CVM (0).
CVMCYTKCVM / CYTK
Capitalization6.58M3.71B0%
EBITDA-21.96M-513.62M4%
Gain YTD-82.496-34.056242%
P/E RatioN/AN/A-
Revenue019.2M-
Total CashN/A938M-
Total Debt11.1M791M1%
FUNDAMENTALS RATINGS
CVM vs CYTK: Fundamental Ratings
CVM
CYTK
OUTLOOK RATING
1..100
5153
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
10080
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
9992
P/E GROWTH RATING
1..100
551
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CVM's Valuation (98) in the Biotechnology industry is in the same range as CYTK (100). This means that CVM’s stock grew similarly to CYTK’s over the last 12 months.

CYTK's Profit vs Risk Rating (80) in the Biotechnology industry is in the same range as CVM (100). This means that CYTK’s stock grew similarly to CVM’s over the last 12 months.

CVM's SMR Rating (98) in the Biotechnology industry is in the same range as CYTK (99). This means that CVM’s stock grew similarly to CYTK’s over the last 12 months.

CYTK's Price Growth Rating (92) in the Biotechnology industry is in the same range as CVM (99). This means that CYTK’s stock grew similarly to CVM’s over the last 12 months.

CYTK's P/E Growth Rating (1) in the Biotechnology industry is somewhat better than the same rating for CVM (55). This means that CYTK’s stock grew somewhat faster than CVM’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CVMCYTK
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 19 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 4 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYTK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AHH6.96-0.03
-0.43%
Armada Hoffler Properties
VTRS8.79-0.04
-0.45%
Viatris
TCBI71.69-0.64
-0.88%
Texas Capital Bancshares
OPBK12.31-0.26
-2.11%
OP Bancorp
AMST2.74-0.07
-2.49%
Amesite

CYTK and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYTK has been loosely correlated with IDYA. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CYTK jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYTK
1D Price
Change %
CYTK100%
-0.96%
IDYA - CYTK
48%
Loosely correlated
-0.80%
KRYS - CYTK
47%
Loosely correlated
+0.28%
ACLX - CYTK
45%
Loosely correlated
-2.54%
TRDA - CYTK
44%
Loosely correlated
-3.80%
ROIV - CYTK
44%
Loosely correlated
-2.74%
More